Etest를 이용한 피부사상균의 항진균제 감수성 검사

키워드

참고문헌 (38)

1. Roh JY, "Korean Dermatological Association, Dermatology. 5th ed", pp.346~356 (2008), Ryo moon gak
2. Nelson MM, "Superficial fungal infections: dermatophytosis, onchomycosis, tinea nigra, piedra. in Fitzpatrick's dermatology in medicine. 6th ed", pp.1989~20 (2003), Mcgraw-Hill
3. Kwon-Chung KJ, "Medical mycology", pp.105~161 (1992), Lea & Febiger
4. Weitzman I, "The dermatophytes", Clin Microbiol Rev, 8, pp.240~259 (1995)
5. Fernandez-Torres B, "Collaborative evaluation of optimal antifungal susceptibility testing conditions of dermatophytes", J Clin Microbiol, 40, pp.3999~4003 (2002)
6. Barchiesi F, "In vitro activity of posaconazole against clinical isolates of dermatophytes", J Clin Microbiol, 39, pp.4208~4209 (2001)
7. Fernandez-Torres B, "In vitro activities of 10 antifungal drugs against 508 dermatophyte strains", Antimicrob Agents Chemother, 45, pp.2524~2528 (2001)
8. Jessup CJ, "Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates", J Clin Microbiol, 38, pp.341~344 (2000)
9. Parro AM, "Alchorne M. Disseminated dermatophytosis caused by Microsporum gypseum in two patients with the acquired immunodeficiency syndrome", Mycopathologia, 137, pp.9~12 (1997)
10. Squeo RF, "Invasive Trichophyton rubrum resembling blastomycosis infection in the immunocompromised host", J Am Acad Dermatol, 39, pp.379~380 (1998)
11. Tsang P, "Deep dermatophytosis caused by Trichophyton rubrum in a patient with AIDS", J Am Acad Dermatol, 34, pp.1090~1091 (1996)
12. Santos DA, "In vitro activities of four antifungal drugs against Trichophyton rubrum isolates exhibiting resistance to fluconazole", Mycoses, 50, pp.286~289 (2007)
13. Gupta AK, "Evaluation of in vitro resistance in patients with onychomycosis who fail antifungal therapy", Dermatology, 207, pp.375~380 (2003)
14. Mukherjee PK, "Clinical Trichophyton rubrum strain exhibiting primary resistance to terbinafine", Antimicrob Agents Chemother, 47, pp.82~86 (2003)
15. Burkhart CN, "Dermatophytoma: recalcitrance to treatment because of existence of fungal biofilm", J Am Acad Dermatol, 47, pp.629~631 (2002)
16. Millikan LE, "Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients", Cutis, 68(Suppl 1), pp.6~14 (2001)
17. Neiwerth M, "The use of systemic antimycotics in dermatotherapy", Eur J Dermatol, 10, pp.155~160 (2000)
18. Boudghene-Stambouli O, "Antifungal agents in dermatophytic disease: failure of griseofulvin, ketoconazole and itraconazole", Bull Soc Pathol Exot, 83, pp.170~176 (1990)
19. Arikan S, "Current status of antifungal susceptibility testing methods", Med Mycol, 45, pp.569~587 (2007)
20. Shin JH, "Antifungal drug susceptibility", Hanygang Med Rev, 26, pp.79~85 (2006)
21. Fernandez-Torres B, "Interlaboratory evaluation of the Etest for antifungal susceptibility testing of dermatophytes", Med Mycol, 41, pp.125~130 (2003)
22. Da Silva Barros ME, "Antifungal susceptibility testing of Trichophyton rubrum by Etest", Arch Dermatol Res, 299, pp.107~109 (2007)
23. Mendez CC, "Comparison of Etest, disk diffusion and modified CLSI broth microdilution (M38-A) method for in vitro testing of itraconazole, fluconazole, voriconazole against dermatophytes", Med Mycol, 46, pp.119~123 (2008)
24. Caligiorne RB, "In vitro susceptibility of chromoblastomycosis and phaeohyphomycosis agents to antifungal drugs", Med Mycol, 37, pp.405~409 (1999)
25. Vanden Bossche H, "Mechanisms and clinical impact of antifungal drugresistance", J Med Vet Mycol, 32(Suppl 1), pp.189~202 (1994)
26. Kim YJ, "Azole antifungal susceptibility testing of Candida species using E test", Korean J Dermatol, 39, pp.654~659 (2001)
27. Vivas JR, "In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test", Rev Esp Quimioter, 14, pp.191~197 (2001)
28. Espinel-Ingroff A, "In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi", J Clin Microbiol, 39, pp.954~958 (2001)
29. Pfaller MA, "In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference M38-A microdilution methods for determining posaconazole MICs", Diagn Microbiol Infect Dis, 45, pp.241~244 (2003)
30. 고우태, "Etest를 이용한 흑색진균의 항진균제 감수성 검사", 대한의진균학회지, 14(4), pp.163~170 (2009), 대한의진균학회1
31. Clinical and Laboratory Standards Institute (CLSI), "Referance method for broth dilution antifungal susceptibility testing of conidial-forming filamentous fungi", Approved standard CLSI M38-A, ~ (2002)
32. Ghannoum MA, "Intraand interlaboratory study of a method for testing the antifungal susceptibilities of dermatophytes", J Clin Microbiol, 42, pp.2977~2979 (2004)
33. Carrillo-Muñoz AJ, "In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis", Rev Iberoam Micol, 22, pp.110~113 (2005)
34. Santos DA, "Evaluation of broth microdilution antifungal susceptibility testing conditions for Trichophyton rubrum", J Clin Microbiol, 43, pp.1917~1920 (2005)
35. Santos DA, "Establishing a method of inoculum preparation for susceptibility testing of Trichophyton rubrum and Trichophyton", J Clin Microbiol, 44, pp.98~101 (2006)
36. Ghannoum M, "Voriconazole susceptibilities of dermatophyte isolates obtained from a worldwide tinea capitis clinical trial", J Clin Microbiol, 44, pp.2579~2580 (2006)
37. Santos DA, "In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes", Med Mycol, 44, pp.357~362 (2006)
38. Carrillo-Muñoz AJ, "In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis", Int J Antimicrob Agents, 30, pp.157~161 (2007)

관련 논문AI추천